Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival
Angela Shaulov(Beth Israel Deaconess Medical Center), Mark A. Exley(Brigham and Women's Hospital), Lynne Uhl(Hadassah Medical Center), Haesook T. Kim(Dana-Farber Cancer Institute), Ruojie Wang(Massachusetts General Hospital), David Avigan(Beth Israel Deaconess Medical Center), Steven P. Balk(Beth Israel Deaconess Medical Center), Robert Sackstein(Florida International University), Simon Yue(Harvard University Press), Robin Joyce(Beth Israel Deaconess Medical Center)
Cited by 23
Related Papers
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
|New England Journal of Medicine|1995|1.3k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k